These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25596950)

  • 1. A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development.
    Dickson MC; Ludbrook VJ; Perry HC; Wilson PA; Garthside SJ; Binks MH
    Inflamm Res; 2015 Apr; 64(3-4):171-83. PubMed ID: 25596950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative abundance of interferon-stimulated genes STAT1, OAS1, CXCL10 and MX1 in ovine lymph nodes during early pregnancy.
    Zhang L; Cao L; Yang F; Han X; Wang Y; Cao N; Yang L
    Anim Reprod Sci; 2020 Mar; 214():106285. PubMed ID: 32087912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of early pregnancy on expression of interferon-stimulated gene 15, STAT1, OAS1, MX1, and IP-10 in ovine liver.
    Yang L; Li N; Zhang L; Bai J; Zhao Z; Wang Y
    Anim Sci J; 2020; 91(1):e13378. PubMed ID: 32329195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The correlation of myxovirus resistance 1 and 2'5'-ollgoadenylate synthetase 1 with clinical features of systemic lupus erythematosus].
    Li M; Yang NP; Huang XY; Zhao ZY; Zhang J; Liu XX; Pu XY; Dong JL; Ye Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):268-71. PubMed ID: 19462904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation.
    Rascio F; Pontrelli P; Accetturo M; Oranger A; Gigante M; Castellano G; Gigante M; Zito A; Zaza G; Lupo A; Ranieri E; Stallone G; Gesualdo L; Grandaliano G
    J Pathol; 2015 Sep; 237(1):72-84. PubMed ID: 25925804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
    Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
    J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
    Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
    Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.
    Ambrose N; Khan E; Ravindran R; Lightstone L; Abraham S; Botto M; Johns M; Haskard DO
    Clin Exp Immunol; 2015 Sep; 181(3):427-33. PubMed ID: 25982097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OAS1, 2, and 3: Significance During Active Tuberculosis?
    Leisching G; Wiid I; Baker B
    J Infect Dis; 2018 Apr; 217(10):1517-1521. PubMed ID: 29452387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells.
    Ronni T; Matikainen S; Sareneva T; Melén K; Pirhonen J; Keskinen P; Julkunen I
    J Immunol; 1997 Mar; 158(5):2363-74. PubMed ID: 9036986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
    Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
    Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids modulate the interferon signalling pathway.
    Podevin P; Rosmorduc O; Conti F; Calmus Y; Meier PJ; Poupon R
    Hepatology; 1999 Jun; 29(6):1840-7. PubMed ID: 10347128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.
    Saeheng S; Nosoongnoen W; Varothai S; Sathirakul K
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1372-7. PubMed ID: 23057672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.
    Huard C; Gullà SV; Bennett DV; Coyle AJ; Vleugels RA; Greenberg SA
    Br J Dermatol; 2017 May; 176(5):1224-1230. PubMed ID: 27564228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local hyperthermia could induce antiviral activity by endogenous interferon-dependent pathway in condyloma acuminata.
    Zhu LL; Gao XH; Qi R; Hong Y; Li X; Wang X; McHepange UO; Zhang L; Wei H; Chen HD
    Antiviral Res; 2010 Nov; 88(2):187-92. PubMed ID: 20797409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
    Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
    J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic mRNA levels of type I interferon receptor and interferon-stimulated genes in genotype 1b chronic hepatitis C. Association between IFNAR1 mRNA level and sustained response to interferon therapy.
    Taniguchi H; Iwasaki Y; Takahashi A; Shimomura H; Moriya A; Yu PC; Umeoka F; Fujioka S; Koide N; Shiratori Y
    Intervirology; 2007; 50(1):32-9. PubMed ID: 17164555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C.
    Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Garcia A; Moore PA; Yu R; Subramanian GM
    Antivir Ther; 2006; 11(7):901-8. PubMed ID: 17302252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
    Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
    J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
    Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
    J Transl Med; 2007 Jan; 5():7. PubMed ID: 17257431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.